Biotech Values

[biocqr]

ONCE BLUE QURE > Hemophilia B gene therapy cost est @ 4M-6M...


Gene therapies offer dramatic promise but shocking costs

https://www.washingtonpost.com/business/economy/gene-therapies-offer-dramatic-promise-but-shocking-costs/2015/11/11/01f11cf0-824b-11e5-9afb-0c971f713d0c_story.html

Nadeau, of Cowen & Co., said his firm has estimated that Spark Therapeutics’ gene therapy will cost $500,000 per eye. A study published last year in the journal Nature Biotechnology examined current health-care spending on hemophilia B and found that a gene therapy could conceivably be priced as a one-time payment of $4 million to $6 million. The authors argued that paying $150,000 a year as long as the drug works could potentially save the health-care system money.

companion article...

Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia?

http://www.xconomy.com/national/2015/03/23/stop-the-bleeding-can-gene-therapy-finally-cure-hemophilia/?single_page=true